0,922  0,003  CYP2C19 substrate
0,914  0,003  CYP2C9 substrate
0,818  0,004  CTGF expression inhibitor
0,811  0,009  CYP3A4 substrate
0,802  0,009  Teratogen
0,759  0,010  Embryotoxic
0,743  0,007  CYP1A2 substrate
0,724  0,018  Transcription factor NF kappa B inhibitor
0,724  0,026  Antiinflammatory
0,691  0,010  Chemoprotective
0,658  0,013  Antihypercholesterolemic
0,657  0,012  Radioprotector
0,653  0,009  UGT1A9 substrate
0,636  0,007  Antipyretic
0,662  0,037  Apoptosis agonist
0,634  0,020  TNF expression inhibitor
0,591  0,020  Cholesterol antagonist
0,571  0,005  P-glycoprotein inhibitor
0,556  0,003  Neurotrophic factor enhancer
0,560  0,022  Respiratory analeptic
0,546  0,015  AR expression inhibitor
0,547  0,019  Sensitization
0,542  0,016  Chemopreventive
0,520  0,009  Myocardial infarction treatment
0,528  0,020  Spasmolytic
0,513  0,010  Psychostimulant
0,512  0,017  NOS2 expression inhibitor
0,528  0,033  Antibacterial
0,511  0,019  NOS3 expression inhibitor
0,498  0,007  Melanin inhibitor
0,505  0,019  Antiosteoporotic
0,506  0,026  Bone diseases treatment
0,515  0,042  Antineoplastic (lung cancer)
0,493  0,025  CYP2C19 inhibitor
0,472  0,007  Abortion inducer
0,489  0,024  Analeptic
0,478  0,015  Eye irritation, high
0,482  0,022  Antioxidant
0,506  0,057  Caspase 9 stimulant
0,482  0,039  Antipruritic, allergic
0,451  0,009  Contraceptive
0,460  0,018  UGT2B4 substrate
0,487  0,057  Antineoplastic (breast cancer)
0,464  0,043  Immunosuppressant
0,442  0,021  Antiglaucomic
0,424  0,022  Antiparasitic
0,405  0,003  Cannabinoid CB2 receptor antagonist
0,417  0,019  Antihypertriglyceridemic
0,413  0,018  Sedative
0,416  0,022  UGT1A6 substrate
0,419  0,028  Cardiovascular analeptic
0,399  0,008  Interleukin 6 antagonist
0,417  0,026  Proliferative diseases treatment
0,423  0,033  Lipoprotein disorders treatment
0,403  0,017  UGT1A1 substrate
0,406  0,024  Hypolipemic
0,387  0,012  Hair growth stimulant
0,406  0,032  Carcinogenic
0,391  0,017  Antineoplastic (sarcoma)
0,380  0,010  Lipocortins synthesis antagonist
0,379  0,019  Antihelmintic
0,369  0,011  Lipid peroxidase inhibitor
0,384  0,027  Nitric oxide antagonist
0,387  0,034  Hypoxia-inducible factor 1 alpha inhibitor
0,366  0,014  Antipruritic, non-allergic
0,368  0,015  Antianorexic
0,398  0,046  Antifungal
0,389  0,037  Cytotoxic
0,389  0,038  Antineoplastic (glioma)
0,353  0,007  Antifungal enhancer
0,371  0,028  Sodium/bile acid cotransporter inhibitor
0,359  0,016  UGT2B7 substrate
0,384  0,046  ICAM1 expression inhibitor
0,377  0,045  Antineoplastic (brain cancer)
0,407  0,081  Analgesic
0,344  0,019  Antihypotensive
0,346  0,023  Muscle relaxant
0,355  0,036  Antineoplastic (lymphoma)
0,386  0,068  Antileukemic
0,321  0,004  SULT1A1 substrate
0,354  0,041  Cytostatic
0,317  0,006  Antiemetic
0,343  0,041  Free radical scavenger
0,315  0,015  UGT2B15 substrate
0,383  0,086  Antiparkinsonian
0,302  0,011  DNA polymerase I inhibitor
0,353  0,063  Immunostimulant
0,295  0,008  Neurotrophic factor
0,289  0,005  Posttraumatic stress disorder treatment
0,296  0,012  Cholesterol synthesis inhibitor
0,339  0,058  Calcium channel activator
0,325  0,047  Antiprotozoal (Leishmania)
0,345  0,067  Prostate cancer treatment
0,339  0,062  CYP2D6 substrate
0,296  0,020  Interferon gamma antagonist
0,292  0,019  Monophenol monooxygenase inhibitor
0,337  0,066  Antihypertensive
0,328  0,059  Cardioprotectant
0,272  0,005  TRPA1 agonist
0,331  0,067  Hepatic disorders treatment
0,293  0,032  Hepatoprotectant
0,325  0,065  Antineoplastic (ovarian cancer)
0,311  0,064  Antineoplastic (pancreatic cancer)
0,297  0,053  Urologic disorders treatment
0,278  0,034  Peptidyltransferase inhibitor
0,283  0,039  UDP-glucuronosyltransferase substrate
0,244  0,002  Anabolic
0,303  0,064  Antineoplastic (multiple myeloma)
0,250  0,018  Antihyperlipoproteinemic
0,284  0,058  Hypoglycemic
0,231  0,007  Estrogen receptor alpha antagonist
0,258  0,036  Antimutagenic
0,229  0,007  Estrogen agonist
0,234  0,013  Antirickettsial
0,247  0,027  Protein kinase stimulant
0,232  0,014  Sulfotransferase substrate
0,256  0,039  UGT1A4 substrate
0,242  0,027  Skin whitener
0,243  0,031  Antiacne
0,277  0,066  GST M1-1 substrate
0,225  0,017  Antineoplastic antibiotic
0,265  0,058  Antineoplastic (glioblastoma multiforme)
0,308  0,103  Ulceration
0,211  0,007  Prolactin inhibitor
0,220  0,017  Arachidonic acid antagonist
0,291  0,091  Apoptosis antagonist
0,223  0,029  VEGF expression inhibitor
0,221  0,028  Genotoxic
0,275  0,084  Lipoxygenase inhibitor
0,233  0,042  Urinary incontinence treatment
0,206  0,016  Movement disorders treatment
0,193  0,009  Cannabinoid receptor antagonist
0,216  0,032  UGT2B9 substrate
0,197  0,014  Contraceptive female
0,212  0,031  Topoisomerase II inhibitor
0,211  0,030  UGT2B10 substrate
0,282  0,103  Vasodilator, coronary
0,237  0,058  RNA-directed DNA polymerase inhibitor
0,295  0,119  CYP2C9 inhibitor
0,189  0,015  Vanilloid 1 agonist
0,188  0,014  Estrogen antagonist
0,289  0,116  GST A substrate
0,202  0,029  SULT1A3 substrate
0,228  0,059  Mutagenic
0,189  0,020  Adenylate cyclase stimulant
0,196  0,030  Protein-tyrosine phosphatase 1B inhibitor
0,175  0,011  Antiviral (Trachoma)
0,174  0,012  Electron transport complex I inhibitor
0,169  0,008  Antiprotozoal activity enhancer
0,259  0,098  Antineoplastic (colorectal cancer)
0,252  0,094  Antineoplastic (colon cancer)
0,179  0,021  Alcohol dehydrogenase substrate
0,210  0,055  Growth hormone agonist
0,165  0,010  UGT2B11 substrate
0,172  0,020  Aldehyde dehydrogenase substrate
0,241  0,089  5 Hydroxytryptamine uptake stimulant
0,167  0,015  Ca2+-transporting ATPase inhibitor
0,195  0,049  Protein-tyrosine phosphatase inhibitor
0,230  0,085  Antineoplastic (liver cancer)
0,172  0,028  Growth stimulant
0,171  0,026  Coagulant
0,197  0,053  UGT1A3 substrate
0,256  0,113  Interleukin 2 agonist
0,154  0,014  SULT1E1 substrate
0,206  0,071  Anesthetic general
0,262  0,128  Antiprotozoal (Plasmodium)
0,221  0,089  Antineoplastic (cervical cancer)
0,153  0,022  Antispirochetal
0,223  0,091  DNA synthesis inhibitor
0,230  0,100  5 Hydroxytryptamine release stimulant
0,168  0,038  Alkylator
0,166  0,037  Interleukin 4 antagonist
0,200  0,074  Pneumotoxic
0,183  0,058  Toxic, respiratory center
0,149  0,029  UGT2B1 substrate
0,142  0,023  Actinic keratosis treatment
0,160  0,042  Retinoprotector
0,233  0,115  Antihypoxic
0,178  0,060  Prostate disorders treatment
0,246  0,130  Vasodilator, peripheral
0,202  0,086  VCAM1 expression inhibitor
0,126  0,011  SULT1A2 substrate
0,265  0,150  Antiprotozoal
0,290  0,176  5 Hydroxytryptamine release inhibitor
0,134  0,021  Estrogen receptor beta antagonist
0,166  0,054  Skeletal muscle relaxant
0,146  0,035  Choleretic
0,132  0,021  Antihypermotility
0,132  0,024  Thioredoxin inhibitor
0,115  0,007  Estrogen receptor alpha agonist
0,130  0,024  Paget's disease treatment
0,127  0,021  Ornithine decarboxylase inhibitor
0,149  0,047  Antihemorrhagic
0,159  0,057  Anesthetic
0,203  0,102  Vasodilator
0,134  0,034  Chronic obstructive bronchitis treatment
0,205  0,106  Antineoplastic (renal cancer)
0,135  0,040  HDL-cholesterol increasing
0,146  0,055  Antiseptic
0,157  0,066  NOS3 expression enhancer
0,245  0,156  Antineoplastic (endocrine cancer)
0,189  0,100  Angiogenesis stimulant
0,227  0,139  CYP3A4 inhibitor
0,152  0,064  Antiprotozoal (Coccidial)
0,230  0,143  Antithrombotic
0,110  0,027  Contraceptive male
0,096  0,014  Antimycoplasmal
0,128  0,048  Photosensitizer
0,105  0,027  Na+ K+ transporting ATPase inhibitor
0,097  0,020  Anticholelithogenic
0,092  0,015  Protein 50S ribosomal subunit inhibitor
0,160  0,086  ATPase inhibitor
0,149  0,074  Antiviral (Influenza A)
0,110  0,036  Phosphodiesterase 6D inhibitor
0,094  0,020  Antitreponemal
0,213  0,140  Metabolic disease treatment
0,085  0,014  Estrogen receptor beta agonist
0,110  0,040  Androgen antagonist
0,102  0,034  Antibiotic
0,119  0,052  Expectorant
0,084  0,017  Hypercalcemia treatment
0,087  0,022  Cannabinoid CB1 receptor antagonist
0,095  0,032  Antiviral (Dengue virus)
0,083  0,021  SULT2A1 substrate
0,086  0,025  Cannabinoid CB1 receptor agonist
0,135  0,074  Farnesoid X receptor antagonist
0,075  0,017  Postcoital contraceptive
0,090  0,031  Dopamine agonist
0,075  0,017  Lipocortins synthesis agonist
0,067  0,009  Glucocorticoid antagonist
0,146  0,091  Uterine stimulant
0,166  0,112  Insulin sensitizer
0,153  0,100  Phospholipase C inhibitor
0,209  0,156  Caspase 3 stimulant
0,079  0,028  Aromatase inhibitor
0,093  0,042  Vanilloid agonist
0,123  0,074  Papain-like protease (SARS coronavirus) inhibitor
0,071  0,024  Sphingosine kinase inhibitor
0,184  0,137  Antineoplastic (melanoma)
0,052  0,005  Motilin receptor agonist
0,085  0,038  Lipase inhibitor
0,073  0,028  Androgen agonist
0,049  0,004  Toll-Like receptor 4 agonist
0,057  0,012  RNA-directed RNA polymerase stimulant
0,063  0,019  Vanilloid 2 antagonist
0,253  0,209  Cyclophilin D inhibitor
0,253  0,209  Antidiabetic
0,074  0,032  Glutamate (mGluR6) antagonist
0,045  0,003  Vanilloid 2 agonist
0,179  0,141  Cardiotonic
0,048  0,013  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,100  0,064  Bronchodilator
0,103  0,067  Topoisomerase I inhibitor
0,077  0,042  Prokinetic
0,090  0,055  Antineoplastic alkaloid
0,122  0,089  Cachexia treatment
0,063  0,031  Postmenopausal disorders treatment
0,104  0,072  Cystathionine beta-synthase inhibitor
0,077  0,046  CDC25A inhibitor
0,120  0,091  Antineoplastic (squamous cell carcinoma)
0,099  0,072  Toll-Like receptor 4 antagonist
0,034  0,007  Hedgehog signaling activator
0,099  0,073  Skin irritative effect
0,068  0,042  Leukotriene antagonist
0,057  0,032  Leukotriene B4 antagonist
0,128  0,105  Antifungal (Cryptococcus)
0,051  0,029  Cholesterol esterase inhibitor
0,037  0,015  ATP citrate lysase inhibitor
0,040  0,018  Squalene synthetase inhibitor
0,155  0,135  Aldehyde oxidase inhibitor
0,078  0,061  Glycine receptor antagonist
0,056  0,040  Pregnane X receptor antagonist
0,116  0,100  Acaricide
0,150  0,136  CYP2B6 inhibitor
0,026  0,012  Prostaglandin F2 alpha agonist
0,140  0,126  Antiarrhythmic
0,091  0,077  Glutathione S-transferase substrate
0,139  0,127  LDLR expression enhancer
0,041  0,030  Hypogonadism treatment
0,040  0,030  Sphingosine kinase 1 inhibitor
0,034  0,024  HMG CoA reductase inhibitor
0,045  0,036  Potassium channel Kv1.3 blocker
0,147  0,139  Antiulcerative
0,115  0,107  Psychosexual dysfunction treatment
0,015  0,010  Antibiotic Tetracycline-like
0,033  0,028  Calcium-independent phospholipase A2 inhibitor
0,067  0,062  Glycine receptor agonist
0,034  0,029  Antibiotic Aminoglycoside-like
0,138  0,135  Non-steroidal antiinflammatory agent
0,052  0,051  Acetyl-CoA transferase 2 inhibitor
0,020  0,019  Leukotriene B4 receptor 2 antagonist
0,011  0,010  Glucocorticoid agonist
0,019  0,019  Corticosteroid-like

